Status:
RECRUITING
The Influence of Standardized Process Management of Laryngeal Mask Airway Placement Based on Pressure Monitoring on the Incidence of Adverse Reactions in Elderly Patients During the Perioperative Period
Lead Sponsor:
Xuanqi Yang
Collaborating Sponsors:
First Affiliated Hospital of Chongqing Medical University
Conditions:
LMA
Pressure Injury
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The laryngeal mask airway (LMA) is a supraglottic ventilation device designed according to human anatomy. It was developed in 1981 by Dr. Archie Boubrain in the United Kingdom to compensate for the de...
Detailed Description
The laryngeal mask airway (LMA) is a supraglottic ventilation device designed based on human anatomy. It was developed by Dr. Archie Brain from the UK in 1981 to compensate for the deficiencies of tra...
Eligibility Criteria
Inclusion
- Age ≥60 years old
- Non-cardiothoracic surgery and head and neck surgery
- Elective surgery
- ASA I-III grade
- NYHA cardiac function class I-II
- The operation time is expected to be ≥30 minutes and ≤2 hours
- 5≤BMI (kg/m2) ≤24.9
Exclusion
- Change to emergency surgery
- Difficult airway that can be predicted before operation, such as difficulty in opening mouth and limited neck movement
- Loose teeth
- Laryngeal obstruction, laryngeal edema, laryngeal abscess, acute airway inflammation, full stomach, acute abdomen, abdominal trauma, drug poisoning, gastrointestinal bleeding
- Complicated with chronic obstructive pulmonary disease, asthma and other respiratory diseases
- Allergic to laryngeal mask materials
- Non-supine position
- Inability to cooperate with the investigator for any reason
- Taking other investigational drugs or participating in other clinical trials within 3 months before study entry
- The investigators considered it inappropriate to be included in the study
Key Trial Info
Start Date :
May 9 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT06954857
Start Date
May 9 2025
End Date
March 31 2027
Last Update
July 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China